Reuters logo
BRIEF-Mithra Pharmaceuticals signs license and exclusive supply agreement with Fuji Pharma
June 28, 2017 / 6:08 AM / 4 months ago

BRIEF-Mithra Pharmaceuticals signs license and exclusive supply agreement with Fuji Pharma

June 28 (Reuters) - MITHRA PHARMACEUTICALS SA:

* SIGNS LICENSE AND EXCLUSIVE SUPPLY AGREEMENT WITH FUJI PHARMA FOR DONESTA IN JAPAN AND ASEAN

* DONESTA IS PRODUCT OF MITHRA IN HORMONE THERAPY (HT), WHOSE PHASE II DOSE RESEARCH STUDY IS CURRENTLY UNDERWAY, MAIN RESULTS ARE EXPECTED AT END Q1 2018

* CO IS ENTITLED TO EUR 1 MILLION FOR SIGNING, IN ADDITION TO FUTURE TWO-DIGIT MILESTONES RELATED TO DEVELOPMENT, REGULATORY ASPECTS AND COMMERCIALIZATION SOURCE TEXT: bit.ly/2sgdWNh FURTHER COMPANY COVERAGE: (Gdynia Newsroom:)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below